HIV Antiviral Compound Licensed To Guangdong Lantai Viewland Pharmaceutical
Aggregated Source: ChinaCSR.com
March 8, 2007|
Sweden's Medivir AB and Guangdong Lantai Viewland Pharmaceutical have signed a licensing agreement for MIV-160 (MV026048), a non-nucleoside HIV reverse transcriptase inhibitor in late pre-clinical development.
Original URL: Click here to visit original article
Copyright ChinaCSR.com
|
Original URL: Click here to visit original article
Copyright ChinaCSR.com
Email This Post